is working for you! Attend the 8th annual Foundation-Thomas K Hunt lecture at the virtual WHS meeting July 25 Margaret A. Liu obtained an M.D. from Harvard Medical School, a B.A. in Chemistry, summa cum laude, from Colorado College, and passed the Epreuve pour le Diplôme d’Enseignement, à l’unanimité (judges’ unanimous decision), in piano from the Ecole Normale de Musique de Paris. She completed Internship and Residency in Internal Medicine and a Fellowship in Endocrinology, all at Massachusetts General Hospital/Harvard Medical School. Previous visiting, faculty, and adjunct faculty appointments were at the Massachusetts Institute of Technology, Harvard Medical School, and The University of Pennsylvania, respectively. Working with Prof. Herman Eisen, known for his seminal work on antibody binding, elucidating the T cell receptor sharpened her immunological skills while a Margaret A. Liu, MD, DSchc, MDhc, FISV Visiting Scientist at MIT. Later while at Merck, she worked closely Karolinska Institutet in Stockholm with Dr. Maurice Hilleman, the legendary vaccinologist who developed more than 40 vaccines. UCSF, San Francisco Use of gene-based vectors for the development of preventions CEO-designate Pax Therapeutics and treatments for infectious diseases and cancer, specifically Saturday July 25, 2020; 10:00AM ET vaccines and immunotherapeutics is Dr. Liu’s expertise. Two of the technologies that she pioneered have now been developed by companies into licensed products: bispecific antibodies for cancer therapy, and DNA vaccines for veterinary applications and which are in numerous human clinical trials for vaccines (for example, one of the first COVID-19 vaccine clinical trials), gene therapy, and immunotherapy for cancer, autoimmune diseases, and allergy. Dr. Liu currently is CEO-designate of PAX Therapeutics, a nascent biotech company using gene delivery of VEGF to optimize healing of ligaments and tendons after surgical repair for rupture. She also consults in the fields of vaccines and immunotherapy for companies, universities, and non-governmental, scientific governmental organizations and international agencies such as WHO, and is a director at Ipsen Pharma. Previous roles included: Senior Director at Merck Research Laboratories, Vice President of Vaccines Research and Gene Therapy at Chiron Corporation, Senior Advisor in Vaccinology at the Bill & Melinda Gates Foundation, Vice-Chairman of Transgene, and Executive Vice-Chair of the International Vaccine Institute (IVI), an independent international organization with signatory countries in Seoul, Korea established by UNDP. Dr. Liu is a Foreign Adjunct Professor at the Karolinska Institutet in Stockholm and an Adjunct Full Professor at the University of California, San Francisco. She is the Chairman of the Board and President Emeritus of the International Society for Vaccines. Dr. Liu has received numerous awards and honors including an NIH Physician Scientist Award. She was invited by the Nobel Committee to lecture in the Karolinska Research Lecture series, was named one of “The 50 Most Important Women in Science” by Discover magazine, has multiple patents, and has been selected for numerous honorary lectureships.She has also had the conferral of two honorary doctorates, the most recent being Medical Doctor honoris causa from the Karolinska Institutet, Stockholm, Sweden. 235 Plain Street, Suite 501 Providence, RI 02905 www.woundhealingfoundation.org WHF is a 501(c)(3) non-profit organization .